12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks experienced significant movements. Heart Test Laboratories, NeuroOne Medical Tech, PaxMedica, Blue Water Biotech, OpGen, and Avinger saw their stocks rise, with increases ranging from 10.63% to 22.4%. On the other hand, Alterity Therapeutics, UpHealth, First Wave BioPharma, SILO Pharma, TRACON Pharma, and Altamira Therapeutics faced declines between 10.3% and 19.8%. Market caps for these companies vary, with the smallest at $2.6 million and the largest at $34.8 million.
November 23, 2023 | 1:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avinger's stock saw a 10.63% increase to $3.33, with a market cap of $4.5 million.
The double-digit percentage rise suggests a bullish short-term impact due to investor trading activity.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Blue Water Biotech's shares went up by 12.11% to $0.36, with a market cap of $6.4 million.
The recent Q3 earnings could be influencing the stock's positive performance, potentially leading to short-term growth.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Heart Test Laboratories' stock rose 22.4% to $0.24 with a market cap of $5.3 million.
The significant pre-market increase suggests positive investor sentiment which could lead to a short-term uptrend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
NeuroOne Medical Tech's stock increased by 14.68% to $1.46, with a market cap of $34.8 million.
The pre-market gain indicates a bullish trend that may persist in the short term, reflecting investor optimism.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
OpGen's stock increased by 11.7% to $0.46, with a market cap of $4.9 million.
The pre-market rise may indicate a positive short-term outlook for the stock, driven by investor sentiment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
PaxMedica's stock rose by 13.48% to $0.91 in the pre-market.
The upward movement in pre-market trading could lead to continued short-term positive momentum.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Alterity Therapeutics' stock fell by 19.8% to $1.91, with a market cap of $7.7 million.
The significant drop in pre-market could lead to a negative short-term trend as investor confidence may be waning.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Altamira Therapeutics' stock dropped 10.3% to $0.33, with a market cap of $2.6 million.
The pre-market drop suggests a bearish outlook that could continue in the short term, influenced by market sentiment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
First Wave BioPharma's stock went down by 17.61% to $0.22, with a market cap of $2.9 million.
The downward movement indicates potential short-term negative pressure on the stock due to investor sentiment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
SILO Pharma's shares fell by 13.59% to $1.59, with a market cap of $4.9 million.
The pre-market decrease could be a sign of short-term bearishness, possibly due to investor concerns.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
TRACON Pharma's stock decreased by 11.2% to $0.19, with a market cap of $6.0 million.
The stock's decline in pre-market trading may reflect short-term negative sentiment among investors.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
UpHealth's stock decreased by 17.79% to $0.65, with a market cap of $11.1 million.
The pre-market decline suggests a bearish sentiment that could negatively affect the stock in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90